Home

Abbott Laboratories (ABT)

133.27
+0.67 (0.50%)
NYSE · Last Trade: May 6th, 4:13 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close132.60
Open131.95
Bid133.26
Ask133.27
Day's Range130.70 - 133.60
52 Week Range99.71 - 141.23
Volume4,251,014
Market Cap233.34B
PE Ratio (TTM)17.31
EPS (TTM)7.7
Dividend & Yield2.360 (1.77%)
1 Month Average Volume7,980,286

Chart

About Abbott Laboratories (ABT)

Abbott Laboratories is a global healthcare company that specializes in the development of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals. The company focuses on innovation to improve patient outcomes and enhance the quality of life for individuals worldwide. Abbott is known for its advancements in areas such as cardiovascular care, diabetes management, and nutrition science, providing essential tools and solutions that support healthcare professionals and patients in managing various health conditions. With a strong commitment to research and development, Abbott continually seeks to address unmet medical needs and contribute to the advancement of healthcare globally. Read More

News & Press Releases

1 Mega-Cap Stock Worth Your Attention and 2 to Keep Off Your Radar
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their ability to find new sources of growth.
Via StockStory · May 6, 2025
Jensen Huang, Magic Johnson, Patrick Dempsey, Linda Yaccarino And More Bigwigs Headline Milken Global Conference 2025: What You Need To Knowbenzinga.com
The Milken Institute's 28th annual Global Conference, featuring prominent figures like Jensen Huang, Magic Johnson, and Linda Yaccarino, is focusing on key global issues such as AI, healthcare, and climate resilience.
Via Benzinga · May 5, 2025
Here Are All the Dividend Kings Beating the S&P 500 in 2025 -- and the 2 That Are the Best Stocks to Buy Nowfool.com
Via The Motley Fool · May 5, 2025
2 Stocks, 2 Decades, $200. Is This the Long-Term Dividend Play for Your Portfolio?fool.com
Via The Motley Fool · May 3, 2025
If A Recession Hits, Will Medical Stocks Be A Safe Haven For Investors — Again?investors.com
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via Investor's Business Daily · May 1, 2025
Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potentialchartmill.com
Abbott Laboratories (NYSE:ABT) Shows Strong Technical Breakout Potential
Via Chartmill · May 1, 2025
A Look Into Abbott Laboratories Inc's Price Over Earningsbenzinga.com
Via Benzinga · April 28, 2025
3 Dividend Stocks to Buy and Hold for the Next Decadefool.com
Via The Motley Fool · April 28, 2025
If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy
AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio.
Via MarketBeat · April 25, 2025
What To Expect From Penumbra’s (PEN) Q1 Earnings
Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know.
Via StockStory · April 22, 2025
Earnings To Watch: ResMed (RMD) Reports Q1 Results Tomorrow
Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for.
Via StockStory · April 22, 2025
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for.
Via StockStory · April 22, 2025
Earnings To Watch: Intuitive Surgical (ISRG) Reports Q1 Results Tomorrow
Medical technology company Intuitive Surgical (NASDAQ:ISRG) will be reporting results tomorrow after market close. Here’s what investors should know.
Via StockStory · April 21, 2025
10 Health Care Stocks Whale Activity In Today's Sessionbenzinga.com
Via Benzinga · April 18, 2025
Dividend Stock Analysis: Abbott Laboratoriestalkmarkets.com
The company is focused on nutritionals, diagnostics, generic drugs, and medical devices.
Via Talk Markets · April 18, 2025
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earningsbenzinga.com
Via Benzinga · April 17, 2025
5 Dividend Aristocrats® So Good You'll Never Want to Sellfool.com
Turn $180 into $7M? These 5 Dividend Aristocrats show how it's possible.
Via The Motley Fool · April 17, 2025
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviewsbenzinga.com
Via Benzinga · April 17, 2025
Tariff-Resistant Abbott Laboratories on Track for New Highs
Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.
Via MarketBeat · April 17, 2025
US Stocks Likely To Open Higher Ahead Of Festive Weekend: 'Current Equity Levels Offer An Attractive Entry Opportunity'benzinga.com
U.S. stock futures rose on Thursday ahead of the long weekend, with Good Friday falling on April 18 and Easter Sunday on April 20.
Via Benzinga · April 17, 2025
Nasdaq Dips 3% Amid Plunge In Nvidia, AMD: Greed Index Remains In 'Extreme Fear' Zonebenzinga.com
Via Benzinga · April 17, 2025
Healthcare Sector Update: MEDtech And Diagnosticstalkmarkets.com
Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks.
Via Talk Markets · April 16, 2025
Stay informed with the top movers within the S&P500 index on Wednesday.chartmill.com
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill · April 16, 2025
Stocks Sink As Powell Dismisses 'Fed Put' Safety Net, Gold Extends Massive Lead Over Nasdaqbenzinga.com
Powell says tariffs could lead to higher inflation and slower growth, but Fed won't intervene in market losses. Stocks tumble, gold prices rise.
Via Benzinga · April 16, 2025
Discover which S&P500 stocks are making waves on Wednesday.chartmill.com
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · April 16, 2025